Skip to content Skip to navigation

NINDS Exploratory Clinical Trials (R01) PAR-17-122

National Institutes of Health
Funding Sponsor: 
National Institutes of Health
Contact Email:
Funding Deadline: 
May 7, 2018 - 11:59 pm

NINDS Exploratory Clinical Trials (R01) PAR-17-122

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may include Phase 1 and 2 studies of drugs and biologics, feasibility studies of devices, and early studies of surgical, behavioral or rehabilitation therapies.  All exploratory trials must contribute to the justification for, and provide some of the data required to inform a future trial to establish efficacy 

Standard R01 deadlines:  Feb. 5, June 5, Oct. 5

Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7

Expiration date: Jan. 8, 2020

Learn more